<div id="readability-page-1"><div><p>Vcanbio Cell &amp; Gene Engineering Corp., Ltd reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,092.46 million compared to CNY 1,205.9 million a year ago. Net income was CNY 107.91 million compared to CNY 133.51 million a year ago.</p><p>Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago.</p></div></div>

中源协和

<p>中源协和（Vcanbio Cell & Gene Engineering Corp., Ltd）公布了截至 2025 年 9 月 30 日的九个月财报。销售额从去年同期的 12.059 亿元人民币下降至 10.9246 亿元人民币。净收入从 1.3351 亿元人民币降至 1.0791 亿元人民币。持续经营业务的基本和稀释每股收益均为 0.24 元人民币，较去年同期的 0.29 元人民币下降</p>

中源协和细胞基因工程股份有限公司公布了截至2025年9月30日的九个月财务业绩